POLYCYTHEMIA VERA. II. COURSE AND THERAPY
Authors: P CALABRESI, O O MEYER
Journal: Annals of Internal Medicine (1959)

Article1 May 1959POLYCYTHEMIA VERA. II. COURSE AND THERAPYPAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P.PAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-50-5-1203 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe successful use of radioactive phosphorus for the treatment of polycythemia vera was first reported by Lawrence9in 1940. By 1946 there was substantial agreement that this was the treatment of choice for this condition.13, 14Since that time the general availability of this isotope to larger medical centers has allowed the study of appreciable numbers of cases by single clinics. From this opportunity a better understanding of the course and complications of this disease process has come forth. The physical and biologic characteristics of P32, as well as the rationale for its use in polycythemia vera, have been well...Bibliography1. Vaquez H: Sur une forme spéciale de cyanose s'accompagnant d'hyperglobulie excessive et persistente, Compt. rend. Soc. de biol. 4: 384, 1892. Google Scholar2. SaundbyRussell RJW: An unexplained condition of chronic cyanosis, with the report of a case, Lancet 1: 515, 1902. CrossrefGoogle Scholar3. Osler W: Chronic cyanosis with polycythemia and enlarged spleen; a new clinical entity, Am. J. M. Sc. 126: 187, 1903. CrossrefGoogle Scholar4. Osler W: A clinical lecture on erythremia, Lancet 1: 143, 1908. Google Scholar5. Wintrobe MM: Osler's chronic cyanotic polycythemia with splenomegaly, Bull. Johns Hopkins Hosp. 85: 75, 1949. Google Scholar6. Harrop GA: Polycythemia, Medicine 7: 291, 1928. Google Scholar7. Weber FP: Polycythemia, erythrocytosis and erythremia (Vaquez-Osler disease), 1921, H. K. Lewis & Co., London. Google Scholar8. RosenthalBassen NF: Course of polycythemia, Arch. Int. Med. 62: 903, 1938. CrossrefGoogle Scholar9. Lawrence JH: Nuclear physics and therapy: preliminary report on a new method of treatment of leukemia and polycythemia, Radiology 35: 51, 1940. CrossrefGoogle Scholar10. DameshekHenstell WHH: The diagnosis of polycythemia, Ann. Int. Med. 13: 1360, 1940. LinkGoogle Scholar11. Hall BE: Therapeutic use of radiophosphorus in polycythemia vera, leukemia and allied diseases, in The use of isotopes in biology and medicine, 1948, University of Wisconsin Press, Madison. Google Scholar12. Lawrence JH: The control of polycythemia by marrow inhibition, J. A. M. A. 141: 13, 1949. CrossrefMedlineGoogle Scholar13. ReinhardMooreBierbaumMoore EHCVOSS: Radioactive phosphorus as a therapeutic agent, J. Lab. and Clin. Med. 31: 107, 1946. MedlineGoogle Scholar14. Erf LA: Radiophosphorus as the treatment of choice in primary polycythemia, Am. J. Med. 1: 362, 1946. CrossrefMedlineGoogle Scholar15. WisemanRohnBouroncleMyers BKRJBAWG: The treatment of polycythemia vera with radioactive phosphorus, Ann. Int. Med. 34: 311, 1951. LinkGoogle Scholar16. Videbaek A: Polycythemia vera (course and prognosis), Acta med. Scandinav. 138: 179, 1950. CrossrefMedlineGoogle Scholar17. Wasserman LR: Polycythemia vera—its course and treatment: relation to myeloid metaplasia and leukemia, Bull. New York Acad. Med. 30: 343, 1954. MedlineGoogle Scholar18. LawrenceBerlinHuff JHNIRL: The nature and treatment of polycythemia, Medicine 32: 323, 1953. CrossrefMedlineGoogle Scholar19. Dameshek W: Some observations in polycythemia vera, Bull. New England M. Center 2: 53, 1954. Google Scholar20. Wintrobe MM: Clinical hematology, 1956, Lea & Febiger, Philadelphia. Google Scholar21. Sohval AR: Hepatic complications in polycythemia vera, Arch. Int. Med. 62: 925, 1938. CrossrefGoogle Scholar22. Meyer OO: Clinical radiation therapy, edited by Pohle, E. A., 1950, Lea & Febiger, Philadelphia. Google Scholar23. Dameshek W: Physiopathology and course of polycythemia vera as related to therapy, J. A. M. A. 142: 790, 1950. CrossrefMedlineGoogle Scholar24. ReznikoffFootBethea PNCJM: Etiologic and pathologic factors in polycythemia vera, Am. J. M. Sc. 189: 753, 1935. CrossrefGoogle Scholar25. TinneyHallGiffin WSBEHZ: Cardiac disease and hypertension in polycythemia vera, Proc. Staff Meet., Mayo Clin. 18: 94, 1943. Google Scholar26. KotnerTritt LMJH: Chorea complicating polycythemia vera, Ann. Int. Med. 17: 544, 1942. LinkGoogle Scholar27. WilburOchsner DLHC: The association of polycythemia vera and peptic ulcer, Ann. Int. Med. 8: 1667, 1935. LinkGoogle Scholar28. TinneyPolleyHallGiffin WSHFBEHZ: Polycythemia vera and gout: report of eight cases, Proc. Staff Meet., Mayo Clin. 20: 49, 1945. Google Scholar29. Hickling RA: Gout, leukemia, and polycythemia, Lancet 1: 57, 1953. CrossrefMedlineGoogle Scholar30. YuWeissmannSharneyKupferGutman TFBLSA: On the biosynthesis of uric acid from glycine-N15 in primary and secondary polycythemia, Am. J. Med. 21: 901, 1956. CrossrefMedlineGoogle Scholar31. Forsell J: Polycythemia in a patient with hypernephroma, Nord. med. 30: 1415, 1946. Google Scholar32. SpodaroForkner ACE: Benign familial polycythemia, Arch. Int. Med. 52: 593, 1933. CrossrefGoogle Scholar33. NadlerCohn SBI: Familial polycythemia, Am. J. M. Sc. 198: 41, 1939. CrossrefGoogle Scholar34. LawrenceGoetsch JHAT: Familial occurrence of polycythemia and leukemia, California Med. 73: 361, 1950. MedlineGoogle Scholar35. LinmanBethell JWFH: The plasma erythropoietic-stimulating factor in man, J. Lab. and Clin. Med. 49: 113, 1957. MedlineGoogle Scholar36. Erslev AJ: Humoral regulation of red cell production, Blood 8: 349, 1953. CrossrefMedlineGoogle Scholar37. HaynalGraf EF: The role of the hypophyseal-hypothalamic system in the pathogenesis of erythraemia and symptomatic polycythaemias, Acta med. Scandinav. 139: 61, 1950. CrossrefGoogle Scholar38. ContopoulosEllisSimpsonLawrenceEvans ANSMEJHHM: Production of polycythemia in hypophysectomized rats by the pituitary erythropoietic factor, Endocrinology 55: 808, 1954. CrossrefGoogle Scholar39. CalabresiMeyer POO: Polycythemia vera. II. Course and therapy, Ann. Int. Med. 50: 1203, 1959. Google Scholar40. LawrenceRosenthal JHRL: Multiple myeloma associated with polycythemia, Am. J. M. Sc. 218: 149, 1949. CrossrefMedlineGoogle Scholar41. Turk W: Beitrage zur Kenntnis des Symptomenbildes Polyzythamie mit Milztumor und "Zyanose," Wien. klin. Wchnschr. 17: 153, 189, 1904. Google Scholar42. NewmanFeltmanDevlin WJAB: Pulmonary function studies in polycythemia vera, Am. J. Med. 11: 706, 1951. CrossrefMedlineGoogle Scholar43. RattoBriscoeMortonComroe OWAJWJH: Anoxemia secondary to polycythemia and polycythemia secondary to anoxemia, Am. J. Med. 19: 958, 1955. CrossrefMedlineGoogle Scholar44. NormanAllen ILEV: The vascular complications of polycythemia, Am. Heart J. 13: 257, 1937. CrossrefGoogle Scholar45. Bliss TL: Basal metabolism in polycythemia vera, Ann. Int. Med. 2: 1155, 1929. LinkGoogle Scholar46. StroebelHallPease CFBEGL: Evaluation of radiophosphorus therapy in primary polycythemia, J. A. M. A. 146: 1301, 1951. CrossrefMedlineGoogle Scholar47. CasselsMorse DEM: The arterial blood gases, the oxygen dissociation curve, and the acid-base balance in polycythemia vera, J. Clin. Investigation 32: 52, 1953. CrossrefMedlineGoogle Scholar48. GriefensteinKingLatchComroe FERMSSJH: Pulmonary function studies in healthy men and women 50 years and older, J. Appl. Physiol. 4: 641, 1952. CrossrefMedlineGoogle Scholar49. StroebelLaw CFWM: Polycythemia vera, M. Clin. North America 40: 1045 (July) 1956. CrossrefMedlineGoogle Scholar50. Lawrence JH: Polycythemia: physiology, diagnosis and treatment, Modern Medical Monographs, 1955, Grune and Stratton, New York. Google Scholar51. CalabresiMeyer POO: Polycythemia vera. I. Clinical and laboratory manifestations, Ann. Int. Med. 50: 1182, 1959. LinkGoogle Scholar52. Congdon CC: Radiation as a factor in experimental lymphomas and leukemias, Proceedings of the Third National Cancer Conference, 1956, J. B. Lippincott Co., Philadelphia, p. 330. Google Scholar53. MinotBuckman GRTE: Erythremia (polycythemia rubra vera), Am. J. M. Sc. 166: 469, 1923. CrossrefGoogle Scholar54. SchwartzEhrlich SOL: The relationship of polycythemia vera to leukemia; a critical review, Acta haemat. 4: 129, 1950. CrossrefMedlineGoogle Scholar55. TinneyHallGriffin WSBEHZ: Hematologic complications of polycythemia vera, Proc. Staff Meet., Mayo Clin. 18: 227, 1943. Google Scholar56. TinneyHallGriffin WSBEHZ: Prognosis of polycythemia vera, Proc. Staff Meet., Mayo Clin. 20: 306, 1945. Google Scholar57. Calabresi P: Myeloproliferative syndrome with leukemia preceding polycythemia vera: a case report, Blood 13: 642, 1958. CrossrefMedlineGoogle Scholar58. Dameshek W: Some speculations on the myeloproliferative syndromes, Blood 6: 372, 1951. CrossrefMedlineGoogle Scholar59. Black-SchaefferStoddard BLD: Panmyelosis and chronic granulocytic leukemia, Am. J. Path. 29: 413, 1953. MedlineGoogle Scholar60. HuttPinnigerWetherly-Mein MSJLG: The myeloproliferative disorders with special reference to myelofibrosis, Blood 8: 295, 1953. CrossrefMedlineGoogle Scholar61. Rosenthal MC: Extramedullary hemapoiesis; myeloid metaplasia, Bull. New England M. Center 12: 154, 1950. MedlineGoogle Scholar62. EllisonGinsbergWatson RRVJ: Triethylenemelamine in polycythemia vera, Cancer 6: 327, 1953. CrossrefMedlineGoogle Scholar63. SpurrSmithBlockJacobson CLTRMLO: A clinical study of the use of nitrogen mustard therapy in polycythemia vera, J. Lab. and Clin. Med. 35: 252, 1950. MedlineGoogle Scholar64. RosenthalRosenthal NRL: Treatment of polycythemia vera with triethylene melamine, Arch. Int. Med. 90: 379, 1952. CrossrefGoogle Scholar65. RichardsonRobbins WLL: The treatment of polycythemia vera by spray irradiation, New England J. Med. 238: 78, 1948. CrossrefMedlineGoogle Scholar66. Wintrobe MM: Management of polycythemia vera, J. Chron. Dis. 4: 462, 1955. CrossrefGoogle Scholar67. LawrenceRosenthalStickneyWasserman JHNMLR: Panels in therapy. III. The treatment of polycythemia vera, Blood 10: 655, 1955. CrossrefMedlineGoogle Scholar68. Castle WB: Polycythemia vera, in Pathologic physiology, edited by Sodeman, W. A., 1956, W. B. Saunders Company, Philadelphia, p. 795. Google Scholar69. KorstClatanoffSchilling DRDVRF: On myelofibrosis, Arch. Int. Med. 97: 169, 1956. CrossrefGoogle Scholar70. FriedellStoraasli HLJP: The therapeutic application of radio-active phosphorus with special reference to the treatment of primary polycythemia and chronic myeloid leukemia, J. Clin. Investigation 28: 1308, 1949. CrossrefMedlineGoogle Scholar71. Moschcowitz E: Essays on the biology of disease; the biology of polycythemia vera, J. Mt. Sinai Hosp. 11: 232, 1944. Google Scholar72. ConleyKowalD'Antonio CLJJ: Polycythemia associated with renal tumors, Bull. Johns Hopkins Hosp. 101: 63, 1957. MedlineGoogle Scholar73. JacobsonGoldwasserFriedPlzak LOEWL: Role of the kidney in erythropoiesis, Nature, London 179: 633, 1957. CrossrefMedlineGoogle Scholar74. Erslev AJ: Erythropoietic function in uremic rabbits, Clin. Res. Proc. 5: 141, 1957. Google Scholar75. ValentineBeckFolletteMillsLawrence WNWSJHHJS: Biochemical studies in chronic myelocytic leukemia, polycythemia vera and other idiopathic myeloproliferative disorders, Blood 7: 959, 1952. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Madison, Wisconsin*Received for publication March 28, 1958.From the Department of Medicine, University of Wisconsin School of Medicine, Madison, Wisconsin, and the National Cancer Institute, National Institutes of Health, Bethesda, Maryland.†Field Investigator, National Cancer Institute.Requests for reprints should be addressed to Department of Medicine, University Hospitals, Madison 6, Wisconsin. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited by32P-therapy in polycythemia veraPresent status of32P-therapy in management of polycythemia veraReport of the Joint Committee for Stroke FacilitiesTreatment of Polycythemia Vera with Azauridine and AzaribineRONALD C. DECONTI, M.D., PAUL CALABRESI, M.D.Watch Out for PolycythemiaDie Therapie der Polycythaemia rubra vera Vaquez-OslerTransitions Among the Myeloproliferative DisordersROBERT M. GLASSER, M.D., RICHARD I. WALKER, M.D.Prediction of the dose of radioactive phosphorus in the treatment of polycythaemia veraPolycythemiaFACTORS CONTROLLING HEMOPOIESIS: EXPERIMENTAL OBSERVATIONS ON THEIR ROLE IN POLYCYTHEMIA VERA*JAMES W. LINMAN, M.D., FRANK H. BETHELL, M.D., F.A.C.P., MARTHA J. LONG, M.S. 1 May 1959Volume 50, Issue 5Page: 1203-1216KeywordsBiologicsOral administrationPhosphorusPolycythemiaPolycythemia vera Issue Published: 1 May 1959 PDF downloadLoading ...